Call Us - We're Easy to Talk To (214) 999-9999

FDA Panel Hearing to Consider Reclassifying Hydrocodone Drug Products

The Milwaukee Journal Sentinel reports that the Drug Enforcement Administration “has again asked the FDA to consider tightening prescribing and other rules on hydrocodone drugs.” The FDA will hold hearings on Jan. 24 and Jan. 25 to consider whether to move hydrocodone products from schedule III to the highly regulated “schedule II” class under which narcotics such as OxyContin (oxycodone) fall. In a briefing document released as background material, FDA scientists said that although “patients taking hydrocodone products might develop moderate or low physical dependence, they would not be expected to develop addiction.” However, Center for Drug Evaluation and Research Deputy Director Dr. Douglas Throckmorton said an analysis conducted internally by scientists at the agency does not reflect the FDA’s “official stance.” He said the agency will refrain from making recommendations until after it has reviewed testimony and received a recommendation from the independent advisory committee, which scheduled the two-day hearing.

From the American Association for Justice news release.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at You will find many more articles and links. Thank you for your time.

Find us on your preferred network